A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD) | MicrobiomeTrials← Back to trialsNCT07431112
A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-03-17Est. Completion: 2028-11
Enrollment target: 54 participants Locations- Clinical Study Center, Melbourne, Australia
- Clinical Study Center 1, Tbilisi, Georgia
- Clinical Study Center 2, Tbilisi, Georgia
- Clinical Study Center, Cambridge, United Kingdom
- Clinical Study Center, London, United Kingdom
- Clinical Study Center, Southampton, United Kingdom
Other microbiome trials you might be interested in
Alpha1-Antitrypsin Deficiency
The liver produces a protein called alpha-1 antitrypsin (AAT). AAT is normally released into the bloodstream. In some pe…
Gainesville, United StatesEst. completion Dec 31, 2031
Alpha-1-antitrypsin DeficiencyEmphysemaArtificial Intelligence (AI)Predictive Learning ModelsMortality PredictionLung Transplantation
Emphysema linked to alpha-1-antitrypsin deficiency (DAAT): towards a better prediction of risks Emphysema caused by alph…
Bron, FranceEst. completion Mar 16, 2031